http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05e9f10fdb222fe484b07669e5b5c1e8
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Pischon |
| name | Tobias Pischon |
| given-name | Tobias |
| organization-name | Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute for Social Medicine, Epidemiology and Health Economics, Charite University Medical Center, Berlin Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Molecular Epidemiology Research Group and Biobank Technology Platform, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Core Facility Biobank, Berlin, Germany; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. From the Franz Volhard Clinic and Max Delbrück Center for Molecular Medicine, Medical Faculty of the Charité, Humboldt University, Berlin, Germany. 6Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany; Molecular Epidemiology Group; Max Delbrueck Center for Molecular Medicine (MDC); Berlin-Buch Germany Department of Epidemiology, German Institute of Human Nutrition Potsdam‐Rehbruecke Nuthetal Germany; Molecular Epidemiology Group, Max Delbrueck Center for Molecular Medicine (MDC) Berlin‐Buch Germany Max-Delbrueck-Centre for Molecular Medicine in the Helmholtz Association (MDC), Molecular Epidemiology Research Group, Berlin, Germany (); Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Max-Delbrueck-Centre for Molecular Medicine in the Helmholtz Association (MDC), Biobank Technology Platform, Berlin, Germany; Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Core Facility Biobank, Berlin,German Molecular Epidemiology GroupMax Delbrück Center for Molecular Medicine Berlin‐BuchBerlin‐Buch Germany Department of Nutrition, Harvard School of Public Health, Channing Laboratory, Boston, Mass 02115, USA. tpischon@hsph.harvard.edu 1IARC (IARC/WHO), Lyon, France; 2National Institute for Public Health and the Environment, Bilthoven, the Netherlands; 3Julius Centre for Health Sciences and Primary Care, University Medical Centre, Utrecht, the Netherlands; 4Data Collection and Exposure Unit, European Food Safety Authority, Parma, Italy; 5German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 6Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; 7Department of Clinical Epidemiology, Aarhus University Hospital Aahrus, Denmark; 8Inserm (Institut National de la Santé et de la Recherche Médicale) ERI 20, EA 4045, and Institut Gustave Roussy, Villejuif, France; 9German Cancer Research Centre, Division of Cancer Epidemiology, Heidelberg, Germany; 10Hellenic Health Foundation; 11Department of Hygiene and Epidemiology, University of Athens Medical School, Athens, Greece; 12Etiologic Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori (National Cancer Institute), Milan, Italy; Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany Molecular Epidemiology Group, Max Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Biobank Technology Platform, Berlin, Germany. Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Core Facility Biobank, Berlin, Germany. Molecular Epidemiology Research Group Max Delbrück Center for Molecular Medicine (MDC) Berlin Germany From the Departments of Epidemiology (C.W., M.B.S., T.P., H.B.) and Pharmacology (H.J.), German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute for Social Medicine, Epidemiology, and Health Economics, Charité University Medicine Berlin, Berlin, Germany (C.W.); Department of Internal Medicine, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease, and Clinical Chemistry, University of Tübingen, Tübingen, Germany (N.S., H.H., A.F.); Public Health... Authors' Affiliations: 1LOCUS for homocysteine and related vitamins, Institute of Medicine, University of Bergen, and Haukeland University Hospital, 2Medical Birth Registry, and Norwegian Institute of Public Health and Primary Health Care, 3Hormone Laboratory, Haukeland University Hospital, and 4Bevital A/S, Bergen, Norway; 5International Agency for Research on Cancer (IARC-WHO), Lyon, France; Departments of 6Clinical Epidemiology and 7Surgical Gastroenterology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark; 8Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; 9INSERM (Institut National de la Santé et de la Recherche Médicale), and Institut Gustave Roussy, Villejuif, France; 10Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Nuthetal, Germany; 11Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 12Institute of Epidemiology, Helmholtz Zentrum München, German Research Centre for Environmental Health Authors' Affiliations: 1International Agency for Research on Cancer, Lyon; 2Inserm (Institut National de la Santé et de la Recherche Médicale) Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy; 3Paris South University, Villejuif, France; 4Division of Epidemiology, Public Health and Primary Care Faculty of Medicine, Imperial College, London; 5Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford; 6Clinical Gerontology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom; 7 National Institute for Public Health and the Environment (RIVM), Bilthoven; 8Department of Gastroenterology and Hepatology; 9Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht (UMCU), Utrecht, the Netherlands; 10German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal; 11Department of Cancer Epidemiology, German Cancer Research Centre, Heidelberg, Germany; 12Institute of Cancer Epidemiology, Molecular Epidemiology Research Group, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany Molecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Robert-Rössle-Straße 10, 13125, Berlin, Germany. tobias.pischon@mdc-berlin.de. 4Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 9Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Robert-Rössle-Straße 10, 13125 Berlin, Germany; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Germany; MDC/BIH Biobank, Max-Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), and Berlin Institute of Health (BIH), Berlin, Germany. Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Molecular Epidemiology Research Group, Berlin, Germany; Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Biobank Technology Platform, Berlin, Germany; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Core Facility Biobank, Berlin, Germany. Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Molecular Epidemiology Research Group, Berlin, Germany; Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Biobank Technology Platform, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Core Facility Biobank, Berlin, Germany; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany From the Departments of Nutrition and Epidemiology (T.P., J.K.P., J.E.M., F.B.H., D.H., E.B.R.), Harvard School of Public Health, Boston, Mass; the Division of Preventive Medicine (J.K.P., J.E.M., K.M.R.) and Channing Laboratory (F.B.H., D.H., E.B.R.), Department of Medicine, Brigham & Women’s Hospital, Harvard Medical School, Boston, Mass; and the Department of Epidemiology (T.P.), German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany. Molecular Epidemiology Research Group, Max Delbrueck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany; Charité – Universitätsmedizin Berlin; DZHK (German Center for Cardiovascular Research), partner site Berlin; MDC/BIH Biobank, Max Delbrueck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany, and Berlin Institute of Health (BIH), Berlin, Germany From the Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke (DIfE), Nuthetal, Germany (S.D., A.F., H.B., D.D.); Department of Food Safety, Federal Institute for Risk Assessment, Berlin, Germany (C.W.); Institute for Social Medicine, Epidemiology, and Health Economics, Charité University Medical Center, Berlin, Germany (C.W.); DZHK (German Center for Cardiovascular Research), Partner Site Berlin, Germany (C.W., T.P.); Institute of Experimental Genetics, Helmholtz... Authors' Affiliations: 1LOCUS for homocysteine and related vitamins, Institute of Medicine, Section for Pharmacology, University of Bergen, and Haukeland University Hospital; 2Medical Birth Registry, and Norwegian Institute of Public Health; and 3UNIFOB, Helse-Bergen, Bergen, Norway; 4IARC-WHO, Lyon, France; 5Department of Clinical Epidemiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark; 6Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; 7Institut National de la Sante et de la Recherche Medicale, ERI 20, EA 4045, and Institut Gustave Roussy, Villejuif, France; 8Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Nuthetal, Germany; 9Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 10Institute of Epidemiology, Helmholtz Zentrum Munchen, German Research Centre for Environmental Health (HMGU), Neuherberg, Germany; 11Department of Hygiene and Epidemiology, Medical School University of Athens and 1 From the Department of Epidemiology (D.D., C.W., K.K.-G., B.B., T.P., and H.B.), German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; the Department of Clinical Chemistry and Pathobiochemistry (J.D.), Otto-von-Guericke University, Magdeburg, Germany; the Institute of Medicine (J.D.), Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway; the Faculty of Health Sciences (K.K.-G.), School of Public Health, University of the Witwatersrand, Johannesburg, South... Molecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin Molecular Epidemiology Research Group; Max Delbrück Center for Molecular Medicine (MDC); Berlin Germany German Institute of Human Nutrition (T.P., H.B.), Potsdam-Rehbrücke, 14558 Nuthetal, Germany 19German Institute of Human Nutrition, Potsdam-Rehbücke, Germany; Authors' Affiliations: 1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany; 2International Agency for Research on Cancer, Lyon, France; 3Department of Gastroenterology and Hepatology, and 4Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht; 5National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 6Division of Epidemiology, Public Health and Primary Care, and 7MRC/HPA Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom; 8Department of Epidemiology, Institute of Public Health, Aarhus University, Aarhus; 9Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; 10Inserm, Centre for Research in Epidemiology and Population Health, U1018, Institut Gustave Roussy, F-94805, and Paris South University, UMRS 1018, F-94805, Villejuif, France; 11Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Ins; Authors' Affiliations: 1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany; 2International Agency for Research on Cancer, Lyon, France; 3Department of Gastroenterology and Hepatology, and 4Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht; 5National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 6Division of Epidemiology, Public Health and Primary Care, and 7MRC/HPA Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom; 8Department of Epidemiology, Institute of Public Health, Aarhus University, Aarhus; 9Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; 10Inserm, Centre for Research in Epidemiology and Population Health, U1018, Institut Gustave Roussy, F-94805, and Paris South University, UMRS 1018, F-94805, Villejuif, France; 11Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Ins Franz‐Volhard‐Klinik, Department of Nephrology and Hypertension, Universitätsklinikum Charité, Berlin, Germany Department of Epidemiology German Institute of Human Nutrition Potsdam‐Rehbrücke Nuthetal Germany; Molecular Epidemiology Group Max Delbrueck Center for Molecular Medicine (MDC) Berlin‐Buch Germany Max‑Delbrück‑Center for Molecular Medicine in The Helmholtz Association, Molecular Epidemiology Research Group, D‑13125 Berlin, Germany From the Division of General Medicine and Primary Care (K.J.M.), Beth Israel Deaconess Medical Center, Boston, Mass; Departments of Nutrition (M.K.J., M.J.S., T.P., E.B.R.) and Epidemiology (M.J.S., J.E.M., T.P., E.B.R.), Harvard School of Public Health, Boston, Mass; Centre for Alcohol Research (M.K.J., M.G.), National Institute of Public Health, Copenhagen, Denmark; Channing Laboratory (M.J.S., J.E.M., E.B.R.) and Division of Preventive Medicine (J.E.M.), Department of Medicine, Brigham and... 4German Institute of Human Nutrition, Potsdam, Germany; Molecular Epidemiology Group Max‐Delbrueck‐Center for Molecular Medicine (MDC) Berlin‐Buch Germany; The Charité – Universitaetsmedizin Berlin Berlin Germany Authors' Affiliations: 1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany; 2International Agency for Research on Cancer, Lyon, France; 3National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 4Department of Gastroenterology and Hepatology, University Medical Center, Utrecht, The Netherlands; 5Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, the Netherlands; 6Division of Human Nutrition, Wageningen University, Wageningen, the Netherlands; 7Division of Epidemiology, Public Health and Primary Care, Imperial College, London, United Kingdom; 8Institute of Clinical Chemistry, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany; 9Department of Epidemiology, School of Public Health, Aarhus University, Aarhus, Denmark; 10Diet, Genes and Environment Danish Cancer Society Research Center, Copenhagen, Denmark; 11Inserm, Centre for Research in Epidemiology and Population Health, Institut G; Authors' Affiliations: 1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany; 2International Agency for Research on Cancer, Lyon, France; 3National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 4Department of Gastroenterology and Hepatology, University Medical Center, Utrecht, The Netherlands; 5Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, the Netherlands; 6Division of Human Nutrition, Wageningen University, Wageningen, the Netherlands; 7Division of Epidemiology, Public Health and Primary Care, Imperial College, London, United Kingdom; 8Institute of Clinical Chemistry, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany; 9Department of Epidemiology, School of Public Health, Aarhus University, Aarhus, Denmark; 10Diet, Genes and Environment Danish Cancer Society Research Center, Copenhagen, Denmark; 11Inserm, Centre for Research in Epidemiology and Population Health, Institut G Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Department of Epidemiology German Institute of Human Nutrition Potsdam‐Rehbruecke Nuthetal Germany; Molecular Epidemiology Group, Max Delbrück Center for Molecular Medicine (MDC) Berlin‐Buch Berlin Germany Department of Charité University Medicine Berlin, Campus Benjamin Franklin, 1220 Berlin, and Institute for Social Medicine, Epidemiology, and Health Economics (S.N.W., T.P.), Charité University Medicine Berlin, Campus Mitte, D-10117 Berlin, Germany; Departments of Epidemiology (C.W., H.B., T.P.), German Institute of Human Nutrition Postdam-Rehbruecke, 14558 Nuthetal, Germany Molecular Epidemiology Group,Max Delbrück Center for Molecular Medicine,Berlin,Germany 1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 12Molecular Epidemiology Group, Max Delbrueck Center for Molecular Medicine (MDC), Berlin-Buch, Germany. Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Molecular Epidemiology Research Group , Berlin , Germany; Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Biobank Technology Platform , Berlin , Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin , Core Facility Biobank, Berlin , Germany; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin , Berlin , Germany 8German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany; Charité–Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany; Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Molecular Epidemiology Research Group, Berlin, Germany; Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Biobank Technology Platform, Berlin, Germany; Berlin Institute of Health at Charité–Universitätsmedizin Berlin, Core Facility Biobank, Berlin, Germany Molecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine (MDC), Berlin, Germany Department of Nutrition and Division of Biological Sciences and; Franz-Volhard-Clinic, Charité, Humboldt-University, 13125 Berlin, Germany Department of Epidemiology; German Institute of Human Nutrition Potsdam-Rehbrücke; Nuthetal Germany; Molecular Epidemiology Group, Max Delbrueck Center for Molecular Medicine (MDC); Berlin-Buch Germany Research Group Head, Molecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine, Berlin, Germany; Professor, Molecular Epidemiology, Charité Universitätsmedizin, Berlin, Germany; Director, MDC/BIH Biobank, Berlin Institute of Health, Berlin, Germany Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Molecular Epidemiology Group, Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, Berlin, Germany Molecular Epidemiology Research Group Max Delbrück Center (MDC) for Molecular Medicine in the Helmholtz Association Berlin Germany; Charité—Universitätsmedizin Berlin Berlin Germany; DZHK (German Center for Cardiovascular Research), partner site Berlin Berlin Germany From the Departments of Nutrition and Epidemiology, Harvard School of Public Health (T.P., S.E.H., G.S.H., W.C.W., E.B.R.), Boston, Mass; Channing Laboratory, Harvard Medical School and Brigham & Women’s Hospital (S.E.H., W.C.W., E.B.R.) and Department of Laboratory Medicine, Children’s Hospital and Department of Pathology, Harvard Medical School (N.R.), Boston, Mass; and Franz-Volhard-Clinic, Charité, Humboldt-University (T.P.), Berlin, Germany. Molecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany; Charité–Universitätsmedizin Berlin, Berlin, Germany; Deutsches Zentrum für Herz-Kreislaufforschung e.V., partner site Berlin, Berlin, Germany; Max Delbrück Center for Molecular Medicine and Berlin Institute of Health Biobank, Berlin, Germany Molecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany; Charité – Universitätsmedizin Berlin, Berlin, Germany; MDC/BIH Biobank, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Berlin Institute of Health (BIH), Berlin, Germany; German Center for Cardiovascular Research (DZHK), partner site Berlin, Berlin, Germany Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany; Berlin Institute of Health (BIH), Berlin, Germany; Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health (BIH), Berlin, Germany; MDC/BIH Biobank, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), and Berlin Institute of Health (BIH), Berlin, Germany From the Departments of Nutrition (T.P., F.M.S., M.J.S., E.B.R.) and Epidemiology (T.P., M.J.S., E.B.R.), Harvard School of Public Health, Boston, Mass; Channing Laboratory (F.M.S., M.J.S., E.B.R.), Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass; Department of Laboratory Medicine (N.R.), Children’s Hospital and Department of Pathology, Harvard Medical School, Boston, Mass; the Department of Epidemiology (T.P.), German Institute of Human Nutrition, Potsdam... |
Incoming Links
Total number of triples: 310.